Trigg Minerals

FORTUNE BAY ACCELERATES DEVELOPMENT AT GOLDFIELDS FOLLOWING STRONG PEA AND FINANCING

Development-ready gold asset in premier mining jurisdiction with funded advancement plan; preparing to initiate project-development and exploration drill program Fortune Bay Corp. (TSXV:

ReeXploration Identifies Large-Scale Uranium Target at Eureka Project, Namibia

Discovery of uranium mineralization in ideal geological setting, supported by regional radiometric anomaly, confirms large Rossing-style target ReeXploration Inc. (TSXV: REE) (FSE: K2I0)

Osisko Intersects 330.6 Metres Averaging 0.46% Cu in Southern Extension at Gaspé

Osisko Metals Incorporated (the ‘ Company or ‘ Osisko Metals ‘) ( TSX: OM,OTC:OMZNF ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is

CHARBONE Confirms Construction Schedule on Track at Sorel-Tracy and Announces the Imminent Start of Equipment Installation Phase

(TheNewswire) Brossard, Quebec TheNewswire

CHARBONE confirme le respect de l’echeancier de construction a Sorel-Tracy et annonce le debut imminent de la phase d’installation des equipements

(TheNewswire) Brossard, Quebec TheNewswire

1911 Gold Announces C$20 Million “Best Efforts” Life Offering and Private Placement

/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / 1911 Gold Corporation (‘

Terra Clean Closes the Acquisition of the Past Producing Uranium Claims in San Rafael Swell, Utah, United States

Terra Clean Energy CORP. (‘ Terra ‘ or the ‘ Company ‘) (CSE: TCEC,OTC:TCEFF, OTCQB: TCEFF FSE: C 9O0) is pleased to

Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie Bornholm LP.

Questcorp Mining Inc. (CSE: QQQ,OTC:QQCMF) (OTCQB: QQCMF) (FSE: D910) (the ‘Company’ or ‘Questcorp’) is pleased to announce that Sorbie Bornholm LP (‘Sorbie’),

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division —